Association of Alcohol Consumption With Fat Deposition in a Community-Based Sample of Japanese Men: The Shiga Epidemiological Study of Subclinical Atherosclerosis (SESSA).
Adult
Aged
Alcohol Drinking
/ epidemiology
Anthropometry
/ methods
Cross-Sectional Studies
Epidemiologic Studies
Humans
Intra-Abdominal Fat
/ diagnostic imaging
Japan
/ epidemiology
Male
Middle Aged
Population Surveillance
Subcutaneous Fat, Abdominal
/ diagnostic imaging
Tomography, X-Ray Computed
/ methods
alcohol consumption
anthropometric obesity indice
fat deposition
visceral adipose tissue
Journal
Journal of epidemiology
ISSN: 1349-9092
Titre abrégé: J Epidemiol
Pays: Japan
ID NLM: 9607688
Informations de publication
Date de publication:
05 Jun 2019
05 Jun 2019
Historique:
pubmed:
1
6
2018
medline:
12
10
2019
entrez:
1
6
2018
Statut:
ppublish
Résumé
Excessive alcohol intake has been shown to be associated with cardiovascular disease via metabolic pathways. However, the relationship between alcohol intake and obesity has not been fully elucidated. We aimed to examine the association of alcohol consumption with fat deposition and anthropometric measures. From 2006-2008, we conducted a cross-sectional study in a population-based sample of Japanese men aged 40 through 79 years. Areas of abdominal visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) were calculated using computed tomography imaging. Based on a questionnaire, we classified participants into five groups according to weekly alcohol consumption, excluding former drinkers: non-drinkers (0 g/week), 0.1-160.9, 161-321.9, 322-482.9, and ≥483 g/week. Multivariable linear regression was used to estimate adjusted means of obesity indices for each group. We analyzed 998 men (mean age and body mass index [BMI], 63.8 years and 23.6 kg/m Higher alcohol consumption was associated with higher VAT area, VAT%, and VAT-to-SAT ratio, independent of confounders, including BMI, in general Japanese men. These results suggest that alcohol consumption may have a potential adverse effect on visceral fat deposition.
Sections du résumé
BACKGROUND
BACKGROUND
Excessive alcohol intake has been shown to be associated with cardiovascular disease via metabolic pathways. However, the relationship between alcohol intake and obesity has not been fully elucidated. We aimed to examine the association of alcohol consumption with fat deposition and anthropometric measures.
METHODS
METHODS
From 2006-2008, we conducted a cross-sectional study in a population-based sample of Japanese men aged 40 through 79 years. Areas of abdominal visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) were calculated using computed tomography imaging. Based on a questionnaire, we classified participants into five groups according to weekly alcohol consumption, excluding former drinkers: non-drinkers (0 g/week), 0.1-160.9, 161-321.9, 322-482.9, and ≥483 g/week. Multivariable linear regression was used to estimate adjusted means of obesity indices for each group.
RESULTS
RESULTS
We analyzed 998 men (mean age and body mass index [BMI], 63.8 years and 23.6 kg/m
CONCLUSIONS
CONCLUSIONS
Higher alcohol consumption was associated with higher VAT area, VAT%, and VAT-to-SAT ratio, independent of confounders, including BMI, in general Japanese men. These results suggest that alcohol consumption may have a potential adverse effect on visceral fat deposition.
Identifiants
pubmed: 29848904
doi: 10.2188/jea.JE20170191
pmc: PMC6522392
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
205-212Références
Diabetes Care. 1999 Sep;22(9):1432-7
pubmed: 10480505
BMJ. 1999 Dec 11;319(7224):1523-8
pubmed: 10591709
Diabetes Care. 2001 May;24(5):925-32
pubmed: 11347756
Am J Clin Nutr. 2003 Jan;77(1):91-100
pubmed: 12499328
Alcohol Clin Exp Res. 2003 Mar;27(3):410-23
pubmed: 12658106
Int J Obes Relat Metab Disord. 1992 Dec;16(12):991-7
pubmed: 1335979
J Hum Hypertens. 2004 Jan;18(1):9-16
pubmed: 14688805
Eur Heart J. 2004 Jul;25(13):1153-62
pubmed: 15231374
Diabetes Care. 2004 Dec;27(12):2954-9
pubmed: 15562213
Invest Radiol. 2005 Feb;40(2):97-101
pubmed: 15654254
Am J Clin Nutr. 1992 May;55(5):943-9
pubmed: 1570801
Int J Obes (Lond). 2005 Dec;29(12):1436-44
pubmed: 16077718
Tohoku J Exp Med. 2006 Feb;208(2):123-32
pubmed: 16434835
Int J Obes (Lond). 2006 Jul;30(7):1163-5
pubmed: 16446744
Circulation. 2007 Jul 3;116(1):39-48
pubmed: 17576866
Circulation. 2008 Feb 5;117(5):605-13
pubmed: 18212276
Am J Clin Nutr. 2008 Apr;87(4):957-63
pubmed: 18400719
Am J Clin Nutr. 2008 May;87(5):1455-63
pubmed: 18469271
Am J Clin Nutr. 2008 Sep;88(3):645-50
pubmed: 18779279
Diabetes Care. 2009 Mar;32(3):505-10
pubmed: 19074991
Eur Heart J. 2009 Apr;30(7):850-6
pubmed: 19136488
Am J Cardiol. 2009 Feb 1;103(3):361-8
pubmed: 19166690
J Clin Endocrinol Metab. 2009 Apr;94(4):1137-44
pubmed: 19174500
Int J Obes (Lond). 2009 Dec;33(12):1437-45
pubmed: 19752876
J Clin Endocrinol Metab. 2009 Dec;94(12):5039-44
pubmed: 19846732
Br J Nutr. 2010 Jun;103(12):1702-5
pubmed: 20100377
Arch Intern Med. 2010 Mar 8;170(5):453-61
pubmed: 20212182
Diabetes Care. 2010 Sep;33(9):2117-9
pubmed: 20460443
Am J Clin Nutr. 1991 Jul;54(1):49-55
pubmed: 2058587
Eur J Clin Nutr. 2011 Oct;65(10):1079-87
pubmed: 21559044
Obesity (Silver Spring). 2011 Sep;19(9):1881-6
pubmed: 21633401
Cardiovasc Diabetol. 2011 Dec 01;10:109
pubmed: 22132774
Ann Nutr Metab. 2012;60(1):52-61
pubmed: 22327000
Int J Obes. 1990 Oct;14(10):893-902
pubmed: 2269582
Lancet. 2012 Dec 15;380(9859):2224-60
pubmed: 23245609
Curr Opin Lipidol. 2013 Aug;24(4):321-6
pubmed: 23511381
Eur J Clin Nutr. 2013 Aug;67(8):841-7
pubmed: 23612511
J Clin Endocrinol Metab. 2013 Jun;98(6):2383-91
pubmed: 23633207
Addiction. 2013 Sep;108(9):1579-89
pubmed: 23692391
J Am Coll Cardiol. 2013 Sep 3;62(10):921-5
pubmed: 23850922
Obes Res Clin Pract. 2014 Jan-Feb;8(1):e16-25
pubmed: 24548573
Med Sci Sports Exerc. 2014 Nov;46(11):2175-83
pubmed: 24658221
Lancet. 2014 Aug 30;384(9945):766-81
pubmed: 24880830
JACC Cardiovasc Imaging. 2014 Dec;7(12):1221-35
pubmed: 25440591
Medicine (Baltimore). 2015 Jun;94(23):e965
pubmed: 26061332
Circulation. 2015 Oct 27;132(17):1639-47
pubmed: 26294660
Atherosclerosis. 2016 Mar;246:141-7
pubmed: 26775119
J Am Heart Assoc. 2016 May 04;5(5):
pubmed: 27146446
Prev Med Rep. 2016 Jun 16;4:225-32
pubmed: 27413686
J Am Heart Assoc. 2016 Aug 29;5(9):
pubmed: 27572823
Rev Esp Cardiol (Engl Ed). 2017 May;70(5):331-337
pubmed: 27765543
BMJ. 2017 Mar 22;356:j909
pubmed: 28331015
J Chronic Dis. 1984;37(7):585-92
pubmed: 6746847
Int J Obes Relat Metab Disord. 1996 Mar;20(3):206-12
pubmed: 8653140
J Clin Invest. 1997 Dec 15;100(12):3105-10
pubmed: 9399957
JAMA. 1998 Dec 2;280(21):1843-8
pubmed: 9846779
Int J Obes Relat Metab Disord. 1998 Dec;22(12):1178-83
pubmed: 9877253